[Antihistaminics in urticaria therapy].
D000962:Antimalarials / Q000627:therapeutic use; D003080:Cold Temperature; D003348:Cortisone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D004837:Epinephrine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives; D008027:Light; D008407:Mast Cells / Q000187:drug effects; D010406:Penicillins / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy; D012189:Retrospective Studies; D014581:Urticaria / Q000188:drug therapy*
D000962:Antimalarials; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010406:Penicillins; D003348:Cortisone; D004837:Epinephrine
Die Stellung der Antihistaminika in der Urtikariatherapie.